title: Imatinib non-responsive chronic eosinophilic leukemia with ETV6-PDGFRA fusion gene.
authors: Hematology, Osaka City General Hospital , Osaka , Japan.
authors: Masahiro
authors: M
authors: Yoshida
authors: Nobuyoshi
authors: N
authors: Tamagawa
authors: Takafumi
authors: T
authors: Nakao
authors: Hiroshi
authors: H
authors: Kanashima
authors: Hideya
authors: H
authors: Ueda
authors: Akiko
authors: A
authors: Murakami
authors: Toru
authors: T
authors: Yorifuji
authors: Takahisa
authors: T
authors: Yamane
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002881:Chromosomes, Human, Pair 12 / Q000235:genetics; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000235:genetics*; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D017404:In Situ Hybridization, Fluorescence; D059785:Karyotype; D007938:Leukemia; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics*; D014178:Translocation, Genetic; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate; D015514:Oncogene Proteins, Fusion; D050783:Proto-Oncogene Proteins c-ets; D020796:Receptor, Platelet-Derived Growth Factor alpha; D012097:Repressor Proteins; D000097764:ETS Translocation Variant 6 Protein